docetaxel anhydrous has been researched along with mk 0663 in 2 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 549 | 173 | 265 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | mk 0663 (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.4586 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 0.23 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.53 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, Y; Cheng, M; Gao, HF; Ji, F; Li, J; Shen, B; Wang, K; Yang, C; Yang, M; Zhang, J; Zhang, L; Zhang, T; Zhu, T | 1 |
1 trial(s) available for docetaxel anhydrous and mk 0663
| Article | Year |
|---|---|
Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial.
Topics: Acute Pain; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Etoricoxib; Female; Humans; Neurotoxicity Syndromes; Taxoids | 2022 |
1 other study(ies) available for docetaxel anhydrous and mk 0663
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |